ClinicalTrials.gg
Status unknownNCT05272904QUILTUpdated Mar 10, 2022

The QUILT Study: Quilting Sutures in Patients Undergoing Breast Cancer Surgery

An interventional study of Quilting and Conventional wound closure in Seroma, sponsored by Canisius-Wilhelmina Hospital. Status unknown at 1 site in Netherlands. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-10.

Sponsored by Canisius-Wilhelmina Hospital · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Mar 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
113
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Seroma is the most common complication following breast cancer surgery, with reported incidence up to 90%. Seroma causes patient discomfort, is associated with surgical site infections (SSI), often requires treatment and increases healthcare consumption. The quilting technique, in which the skin flaps are sutured to the pectoralis muscle, leads to a significant reduction of seroma with a decrease in the number of aspirations and surgical site infections. Main objective of this randomized stepped wedge study is to assess the impact of large scale implementation of the quilting technique in patients undergoing mastectomy and/or axillary lymph node dissection. This will be one of the first multicentre prospective studies in which quilting without postoperative wound drain is compared with conventional wound closure. The hypothesis is that quilting is a simple and cost-effective technique to increase textbook outcome. Moreover, it is expected that patient comfort is enhanced by quilting.

Read the detailed description

Seroma is the most common complication following breast cancer surgery, with reported incidence up to 90%. Seroma causes patient discomfort, is associated with surgical site infections (SSI), often requires treatment and increases healthcare consumption. The quilting technique, in which skin flaps are sutured to the pectoralis muscle, leads to a significant reduction of seroma with a decrease in the number of aspirations and surgical site infections. However, implementation is lagging due to unknown side effects, increase in operation time and cost effectiveness. Main objective of this study is to assess the impact of large scale implementation of the quilting suture technique in patients undergoing mastectomy and/or axillary lymph node dissection (ALND).

The QUILT study is a stepped wedge design study performed among nine teaching hospitals in the Netherlands. The study consists of nine steps, with each step one hospital will implement the quilting suture technique. Allocation of the order of implementation will be randomization-based. Primary outcome is 'textbook outcome', i.e.no wound complications, no re-admission, re-operation or unscheduled visit to the outpatient clinic and use of analgesics is not increased postoperative. A total of 113 patients is required based on a sample size calculation.

This will be one of the first multicentre prospective studies in which quilting without postoperative wound drain is compared with conventional wound closure. The hypothesis is that quilting is a simple technique to increase textbook outcome, without increasing health care consumption. Moreover, the expectation is that patient comfort is enhanced by quilting.

02

Conditions studied

  • Seroma

Browse trials for

Keywords

  • Mastectomy
  • Breast cancer surgery
  • Quilting
  • Flap fixation
  • Seroma
  • Complications
  • Shoulder function
  • Pain
  • Cosmetic outcome
  • Health care consumption
03

In context

Seroma

101 studies on the registry are indexed under Seroma; 22 are open to participants now.

This study's planned enrollment of 113 is above the median of 100 across 92 interventional studies indexed under Seroma.

Browse Seroma studies →

Lead sponsor

Canisius-Wilhelmina Hospital is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all patients >18 years of age undergoing mastectomy and/or axillary lymph node dissection
  • be irrespective of the nature of the primary tumour: prophylactic, risk reducing, benign, in situ carcinoma and invasive primary or recurrent carcinoma will be eligible, irrespective of preoperative systemic therapy.

Exclusion criteria

Exclusion Criteria:

  • patients who objected to participation (letter of objection)
  • mentally incompetent patients or otherwise unable to complete a questionnaire
  • immediate breast reconstruction
  • pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
113 participants (estimated)

Study arms

  • Active comparator
    Conventional closure method

    Following mastectomy, skin is closed using subcutaneous sutures followed by intracutaneous running suture. Depending on the surgeons discretion a vacuum closed suction drain was placed beneath the skin flaps.

    Procedure: Conventional wound closure

  • Experimental
    Quilting

    The implemented intervention is the quilting suture technique. The subcutaneous tissue is sutured to the pectoralis muscle placing multiple rows of running sutures. The suture starts at either end of the scar, running back and forth, creating rows of quilting stiches. The rows are placed transversely from the cranial to the caudal end of the wound with 2-3 cm between them, totalling some three to five rows for the cranial flap. The caudal flap is quilted with 2-3 rows in a caudal to cranial fashion. A subcutaneous suture followed by a intracutaneous running suture is used to close the skin. No wound drain is placed.

    Procedure: Quilting

Interventions

  • ProcedureQuilting

    Following mastectomy and/or axillary lymph node dissection, the subcutaneous tissue is sutured to the pectoralis muscle placing multiple rows of running sutures. The suture starts at either end of the scar, running back and forth, creating rows of quilting stiches. The rows are placed transversely from the cranial to the caudal end of the wound with 2-3 cm between them, totalling some three to five rows for the cranial flap. The caudal flap is quilted with 2-3 rows in a caudal to cranial fashion. A subcutaneous suture followed by a intracutaneous running suture is used to close the skin.

  • ProcedureConventional wound closure

    Following mastectomy, skin is closed using subcutaneous sutures followed by intracutaneous running suture. Depending on the surgeons discretion a vacuum closed suction drain was placed beneath the skin flaps.

06

What researchers measure

Primary outcomes

  1. Textbook outcome

    'Textbook outcome' (TO), a combination of outcome parameters reflecting an ideal surgical outcome. Measured 6 months post-operative, the patients postoperative course must comply with the following to meet the definition of TO: * no wound complications * no re-admissions in relation to primary surgery * no re-operation in relation to primary surgery, re-excisions in case of involved margins allowed * no unscheduled visit to the outpatient clinic (depending on the centre one or two postoperative visits are usually scheduled) * postoperative use of analgesics (6 months) is not increased compared to pre-operative

    Time frame: 6 months

Secondary outcomes

  1. All palpation-detected seromas

    Severity of complicaties are scored using the Clavien Dindo Classification of Surgical complications (grade I-V).

    Time frame: 6 months

  2. Clinical significant seroma

    All aspirated seroma. Severity of complicaties are scored using the Clavien Dindo Classification of Surgical complications (grade I-V).

    Time frame: 6 months

  3. Surgical site infections

    Severity of complicaties are scored using the Clavien Dindo Classification of Surgical complications (grade I-V).

    Time frame: 6 months

  4. Bleeding complications

    Severity of complicaties are scored using the Clavien Dindo Classification of Surgical complications (grade I-V).

    Time frame: 6 months

  5. Wound healing problems

    Including skin flap necrosis, wound necrosis, wound dehiscence. Severity of complicaties are scored using the Clavien Dindo Classification of Surgical complications (grade I-V).

    Time frame: 6 months

  6. Duration of surgery

    Duration of surgery in minutes.

    Time frame: 360 minutes

  7. Length of hospital stay

    Length of hospital stay in days: distinguishing between outpatient and inpatient treatment.

    Time frame: 6 months

  8. Unscheduled visits to the outpatient clinic

    Number of unscheduled visits to the outpatient clinic

    Time frame: 6 months

  9. Readmission to the hospital

    Readmission to the hospital related to primary surgery

    Time frame: 6 months

  10. Reoperation

    Reoperation related to primary surgery other than re-excision.

    Time frame: 6 months

  11. Shoulder function

    Assessed using the Disability of the Arm, Shoulder and Hand (DASH) questionnaire. Higher scores mean a worse outcome.

    Time frame: 6 months

  12. Post-operative pain

    Assessed using the visual analogue scale (VAS). Scale 1-10, higher scores mean a worse outcome.

    Time frame: 14 days

  13. Post-operative pain

    Post-operative use of analgesics (paracetamol, NSAID's, opioids).

    Time frame: 6 months

  14. Cosmetic outcome assessed by an independent panel

    an independent panel of four surgeons will blindly assess cosmetics by classifying standardised digital photographs one a 4-point Likert scale with the following categories: poor, fair, good and excellent. Photos are taken in two positions: the first in neutral position with both arms hanging next to the body and the second with both arms raised in 180gr (or as far as possible) elevation.

    Time frame: 6 months

  15. Patient reported satisfaction with breast

    BreastQ questionnaire for mastectomy

    Time frame: 6 months

07

Study locations

1 site
  • Canisius Wilhelmina Hospital
    Nijmegen, Gelderland 6532 SZ, Netherlands
08

References and documents

Individual participant data

Plan to share: Yes — The datasets used and/or analysed during the study are available from the first and senior author on reasonable request.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05272904
Lead sponsor
Canisius-Wilhelmina Hospital
Collaborators
Rijnstate Hospital, OLVG, Martini Hospital Groningen, Catharina Ziekenhuis Eindhoven, St Jansdal Hospital, Bravis Hospital, Diakonessenhuis, Utrecht, St. Antonius Hospital, Gelderse Vallei Hospital
Responsible party
Lotte van Zeelst (Executive investigator, Canisius-Wilhelmina Hospital) — Principal investigator
First posted
Mar 10, 2022
Start date
Aug 1, 2022 (estimated)
Primary completion
Jan 1, 2023 (estimated)
Completion
Jul 1, 2023 (estimated)
Last update
Mar 10, 2022

Study contacts

Lotte van Zeelst, MS
Contact
l.vanzeelst@cwz.nl
0031681515149
Luc Strobbe, PhD
Contact
ljastrobbe@cwz.nl

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion